To address this, we performed a case-control study in a well-characterized NAFLD population and tested the same SNPs which had been previously assembled to provide the genetic score in the pediatric population [13], plus TM6SF2, which has more recently emerged as a genetic key determinant of NAFLD [6, 7]. Here, TM6SF2 is linked to metabolic dysfunction-associated steatotic liver disease.